Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples